Healthcare Leaders Hub

🏠Home 📰News 📝Blog 🎬Videos Advertise Login

Your trusted source for pharmaceutical news, expert insights, and healthcare innovation.

💼𝕏 👥▶️

Content

📰News
📝Blog
🎬Videos

Company

🏠Home
🏢About Us
📧Contact

© 2026 PharmaVoice. All rights reserved. Empowering healthcare leaders.

Privacy Policy•Terms of Service

Pressure intensifies on Novartis as bolt-on deal strategy faces major test | PharmaVoice

Pharma Tech

Pressure intensifies on Novartis as bolt-on deal strategy faces major test

Sep 14, 2026, 10:39 AM

Read Full Article → Pressure intensifies on Novartis as bolt-on deal strategy faces major test

Pressure intensifies on Novartis as bolt-on deal strategy faces major test

Translate article text

Choose a language and wait for the translated text.

Share prices tumbled last week after a key asset from Novartis’ $12bn Avidity deal fumbled in a Phase III trial.